Arbutus Biopharma (ABUS) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| (NASDAQ: ABUS) | Delayed: 4.28 -0.04 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.32 | 52 Week High | $5.88 | |||
| Open | $4.34 | 52 Week Low | $2.65 | |||
| Day High | $4.38 | P/E | N/A | |||
| Day Low | $4.23 | EPS | $0.00 | |||
| Volume | 1,209,253 | |||||
